PATENT CLAIM ANALYSIS

Application Number: 15978271
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["530", "327000"]

Abstract:
The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.

Claim (Index 14):
The method of  claim 1 , wherein the method is used to treat or prevent one or more of rheumatoid arthritis, gout, intestinal bowel disease, oral mucositis, neuropathic pain, inflammatory pain, spinal stenosis-degenerative spine disease, arterial or venous thrombosis, post-operative ileus, aortic aneurysm, osteoarthritis, vasculitis, edema, diabetic macular edema, cerebral edema, intracerebral edema, radiation-induced edema, hemorrhage, pulmonary embolism, stroke, clotting on ventricular assistance devices or stents, head trauma, peri-tumor brain edema, sepsis, stroke, restenosis, systemic lupus erythematosus nephritis, burn injury, embolism, intracerebral hemorrhage, inflammation, acute myocardial infarction, deep vein thrombosis, coagulation, angina, angioedema, joint swelling, lesions in lipopolysaccharides diabetes and its complications, and retinopathy.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.15789
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15459035', '14401697', '14962457', '15614047', '11923307']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7392198721979569
- 35 USC 102 Novelty (BERT): 0.5530369206599821
- Combined Prediction Score: 0.7206015770441594
- Mean Citation Score: 381.31615
- Max Citation Score: 511.45996
- Similarity Product: 295.1116764892816

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test